Antiarrhythmic agents

Sep 05, 2018

Correvio Reports Preliminary Data Collected from >2,000 Brinavess® Treatment Episodes in EU Post-Authorization Safety Study

Aug 16, 2018

Dronedarone Promotes Cardiac Repair After a Heart Attack

Aug 16, 2018

Correvio Announces EU Survey Data Demonstrating Brinavess Successfully Avoided Hospitalization in 85% of Patients

Aug 14, 2018

Correvio Announces Brinavess® Selected as Potentially Eligible for Priority Review in China

Jun 11, 2018

Correvio Provides U.S. Regulatory Update for BRINAVESS

Jun 06, 2018

CardioNXT Announces Enrollment Completion of RADAR Clinical Trial

May 17, 2018

Correvio Announces Enrollment of First Patient in Phase 3 Study Evaluating Brinavess® in China

Apr 17, 2018

Cardiome Completes Enrollment in the Post Approval Safety Study SPECTRUM Evaluating Brinavess®

Feb 08, 2018

Acesion Pharma Receives Approval for Phase I Study in Atrial Fibrillation

Nov 02, 2017

Cardiome Announces Expansion of Global Geographic Footprint for Brinavess®

Oct 19, 2017

Nexus Pharmaceuticals Receives FDA Approval for Procainamide HCL Injection, USP

Aug 21, 2017

Cardiome Provides U.S. Regulatory Update For BRINAVESS

Jun 07, 2017

InCarda Therapeutics Announces Positive Clinical Data Supporting Development of Inhaled Flecainide for the Treatment of Symptomatic Acute Events of Paroxysmal Atrial Fibrillation (PAF)